Venn Life Sciences, a clinical research organisation (CRO), announced on Tuesday the acquisition of Cardinal Systems SAS, a French CRO specialising in Data Management. The acquisition will allow Venn to extend its service of clinical trial management and resourcing solutions. The company will by
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Rolls-Royce Holdings, up 5.6%. The maker of aircraft and marine engines has
LONDON (Alliance News) - Venn Life Sciences Holdings PLC said Thursday said its innovation division Innovenn had secured a patent from the European Patent Office for its anti-acne complex. The complex reduces bacteria, inflammation, excess oil and blocked pores, Venn said. The patent will a
Read moreClinical research organisation Venn Life Sciences announced its innovation division Innoven has secured its first skin patent for its anti-acne complex from the European Patent Office. The patent is expected to reduce bacteria, inflammation, and excess oiliness in less than four hours and will be r
Read moreRightmove's Chairman Scott Forbes has offloaded nearly a half of a holding in the property website group, selling over seven million pounds in shares. Forbes, who has been in his current role since 2005, sold 300,000 shares at an average price of 2,350.81p each, raising a total of £7.05m. Followin
Read more